Managing director in Berkeley Research Group's Healthcare Transactions and Strategy practice
New Executive Order Aims for Most-Favored Nation Pricing: John Barkett, MBA
The new executive order contains multiple provisions if pharmaceutical companies do not offer "most-favored nation" pricing on medication.